HLA-G and cancer: Otherwise, the use of DNA methylation inhibitors such as 5-aza-2′deoxycytidine (5-aza-dC; decitabine) has been proposed in cancer therapy [5–9] and was demonstrated to induce HLA-G expression in vitro [10, 11].